We're excited to invite you to 'Ask The Expert' session in the Wolters Kluwer Booth #1665 at #ASHP2023! Don't miss out on the opportunity to submit your questions today. Join us live on Tuesday, Dec. 5th, from 11:30 AM - 12:00 PM. ow.ly/v7oW50Qc5S1

Discover the pinnacle of Bayesian MIPD with us ASHP! Come see our latest strides: new user features offer unmatched customization. Explore upgraded Bayesian tools, new drug models, and collaborative tools defining the future for #clinicalpharmacist.

Welcome to the world of Bayesian Model-Informed Precision Dosing (MIPD)! 💊

Maza University becomes Argentina's first university to secure Bayesian MIPD, further bolstering the Pharmacy Service at the Central Hospital of Mendoza Province for critical patient care.

Healthcare leaders aiming for transformation in 2024: Elevating care standards isn't a distant dream. With PrecisePK, tailored treatment becomes effortless, aligning dosing precisely to individual patient needs. #HealthcareInnovation #PrecisionMedicine

This review aims to analyze the current literature on the pediatric use of vancomycin and summarize the current knowledge on dosing optimization for target attainment in special patient populations. pubmed.ncbi.nlm.nih.gov/38325652/

If you're working in a clinical pharmacy setting, particularly with an antimicrobial stewardship program and navigating regulatory changes, implementing Bayesian dosing tools can empower your team to optimize workflows and enhance efficiency. wolterskluwer.com/en/expert-insi…

With serum level and drug exposure predictions tailored to your regimen, anticipate changes seamlessly. Instant toxicity warnings empower proactive patient care and personalizing your dosing protocols can help your team plan ahead effectively. Visit our profile for more

In a groundbreaking announcement today, PrecisePK, a global leader in therapeutic drug monitoring software, proudly unveils a transformative partnership with four prominent hospitals across Oahu and Kauai. Kapi’olani Medical Center, Straub Medical Center, Pali Momi Medical

This case study evaluated the suitability of saliva as alternative PK matrix to simplify studies in infants, investigating metamizole, an analgesic used off-label in infants. pubmed.ncbi.nlm.nih.gov/38497339/

In a significant stride towards personalized medicine, PrecisePK proudly announces the launch of three groundbreaking drug models for Bayesian precision dosing: Methotrexate, Cyclosporine and Infliximab. These cutting-edge models are poised to revolutionize therapeutic drug

PrecisePK, a leading figure in precision medicine, proudly announces its strategic collaboration with Pacific University Oregon, heralding a new era in precision medicine research and innovation. Learn more here: precisepk.com/blogs/precisep…

Recognized Excellence: PrecisePK Spotlighted for Advancing Vancomycin Therapy at #KPAC24! We're thrilled to announce PrecisePK's successful debut at the Kuwait Pharmaceutical Advancement Conference & Exhibition (KPAC). Dr. Faisal Alenezi, a distinguished clinical pharmacist at